|
|
|
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Browse
Generic Series: Benchmarking Patent Expiries
Case study and trend analysis of branded sales and volume erosion of pharmaceutical products in the US, and 5EU markets (France, Germany, Italy, Spain and UK), during the first two years of generic competition.
Generic Series: An Introduction to the Canadian Generics Market
The Canadian pharmaceutical market is the 8th largest globally and as such represents an important market for generics manufacturers. Although historically dominated by domestic generics companies, mergers and acquisitions over the last five years hav
Booming US Generic Drug Market
An exhaustive analysis of the US generic market. The report does a thorough investigation of both the drivers as well as restraints impacting the market, and the factors that distinguish the US from other generic markets of the world.
Generic Drugs Market in Brazil (2007-2011)
Brazil is currently the largest market for generic drugs in Latin America and with the current scenario and positive future projections, it is likely to emerge amongst the most potential markets
Generic Drug Market in Canada
Canada represents one of the largest markets for pharmaceuticals in the world, with a huge potential for generics. Generics in 2007 accounted for more then 46% prescriptions and 19% sales.
Indian Generics, 2008-2012: The Growing Threat
Indian pharmaceutical companies are grabbing headlines on an almost daily basis and are increasingly carving out market shares for themselves in the US and many other markets around the world.
Generic League - Market Analysis and Forecasts
The generic industry is a fast evolving market; with significant lucrative opportunities. The generic market is structurally set to experience high growth potential. That wave is partly driven by cost-containment in several national healthcare sectors
Commercial Insight: Generic Cancer Market
Over the next 10 years a significant number of key oncology products, some with blockbuster status, will lose patent protection, thus exposing billions of dollars to generic erosion. While obviously a major threat to the key pharmaceutical players and
The Top 10 Generics Companies: Strategic insight...
This report provides insights into the top 10 generic companies strengths, weaknesses, opportunities and threats in the generic pharmaceutical market, allowing you to tailor the best practice strategies of the generic industry`s leading players to you
The World Generics Market 2006-2011
In sharp contrast to the branded pharmaceutical market, which has stalled in recent year, the generics market is enjoying a period of unprecedented success. In 2005 the world generics market was worth $45bn, a growth of 14% on the previous year...
Global Generics Guide: Part 2 - Benchmarking country markets...
The generics market is undergoing significant change, with intense merger and acquisition activity, a raft of upcoming patent expiries and new legislation being enacted to promote generic prescription in the major markets. In addition, key issues, suc
Generic Competition 2007 to 2011
This unique report will describe in detail which major selling drugs will be affected by patent expiry and the likely financial effect on the producer company.
Results 1 - 15 of 15
|
|
|
|
